Location: Home
  • search
  • go
  • Relate News
  • 4/11/2012China gathers consensus on future essential drug policy direction
  • 4/10/2012Global biosimilars market to reach US$17.9 billion by 2017
  • 4/10/2012CIGB forms joint venture with Chinese pharma firm
  • 4/10/2012PLx Pharma licenses China rights of GI safer aspirin to Lee's Pharma
  • 4/10/2012Novartis faces Chinese lawsuit for alleged ADRs and ADR info omission ...
  • 4/10/2012Haikou Pharma and Chongqing Sino to initiate phase II clinical researc...
  • 4/9/2012Chinese hospital drug market growth expected to continue at slower pac...
  • 4/9/2012MIIT releases pharmaceutical manufacturing company ranking in 2011
  • 4/9/2012NAO reviews progress on EDS implementation in rural areas
  • 4/6/2012Upcoming event: Pharma China Seminar 2012 on May 3 in NJ
  • 4/6/2012Latest study: prevalence of type II diabetes up dramatically in China
  • 4/6/2012Frontage files statin IND in the U.S. for Zhejiang Hisun
  • 4/6/2012Review of Chinese drug registration application and approval in 2011
  • 4/6/2012Pharma M&As intensify in China last year and in the first quarter ...
  • 4/6/2012Biocon inaugurates the largest biosicence research facility in Asia
  • 4/5/2012WiCON will publish China Pharmaceutical Guide 2012 (7th Edition) in Ju...
  • 4/5/2012SFDA seeks to improve quality of generic drugs through bioequivalence
  • 4/5/2012China's latest quit-smoking efforts expected to benefit MNCs
  • 4/4/2012Health Minister Chen Zhu: chronic diseases to slow Chinese economic gr...
  • 4/4/2012Preclinical research confirms efficacy of EpiCept/GNI's F573 for viral...
  • 4/4/2012Pharma sales force grew 18.6% in China last year as it dropped 1.8% gl...
  • 4/4/2012Latest executive moves
  • 4/4/2012Suven granted new patents of NCEs for neurodegenerative diseases in Ch...
  • 4/2/2012China Biologic Products appoints new chairman and VP
  • 4/2/2012China's colorectal cancer drug market expected to nearly double in 201...
  • 4/1/2012Licenses of two pharma companies withdrawn for illegal practices
  • 3/31/2012Pharmaceutical industry growth continues in the first two months of th...
  • 3/31/2012CASS: Income of village clinics have fallen by over 50% after healthca...
  • 3/30/2012Agenix to submit Chinese clinical trial application for its new hepati...
  • 3/30/2012Anaphore acquires Shanghai-based biologic drug developer RuiYi
  • Page:491/720 Total number of articles:21572: [First][<<] [489] [490] [491] [492] [493] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group